Row over savings to State from ‘copycat’ drugs
Generics lobby says biosimilars are being blocked but pharma group disagrees
Biosimilar drug to save HSE millions of euro this year
Even with 30% cut in Pfizer’s blockbuster Enbrel, Biogen’s Benepali delivers extra savings for health budget
Pfizer cuts price of Enbrel to match rival ‘biosimilar’ drug
Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association
‘Biosimilar blocker’ clause could cost HSE over €50m a year
Providers of branded patent drugs and generics face off over provison in draft agreement on drug prices
Generic drugs lobby criticises new agreement
Generics lobby warns Government new deal with Big Pharma will stifle competition
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices